drugset / Trial / NCT01302171

Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy

NCT01302171

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomised, double-blind, placebo-controlled trial to evaluate the role of intracoronary injection of progenitor cells compared to placebo injection in patients with Dilated Cardiomyopathy who have been pre-treated with G-CSF (Granocyte™) injections for 5 days, and patients treated with a 5 day course of G-CSF (Granocyte™) injection only compared to placebo injection

Timeline

Start
2010-08
Primary completion
2012-12
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lenograstim Protein / enzyme biologic 10 ug/kg Subcutaneous